ZIMMER BIOMET HLDGS DL-01/ US98956P1021 /
8/16/2024 8:04:18 AM | Chg. -0.120 | Volume | Bid6:48:34 PM | Ask6:48:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
99.680EUR | -0.12% | - Turnover: - |
100.400Bid Size: 1,000 | 100.700Ask Size: 1,000 | 20.55 bill.EUR | - | - |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 1,207.3000 | 1,210.7000 | 1,224.7000 | 1,288.8000 | 2,062.6000 | ||||||
Intangible Assets | 798.5000 | 740.7000 | 707.7000 | 603.5000 | 8,746.3000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | 5,345.7000 | 21,356.6000 | ||||||
Inventories | 929.8000 | 995.3000 | 1,074.5000 | 1,169 | 2,254.1000 | ||||||
Accounts Receivable | 838.8000 | 884.6000 | 936.6000 | 912.1000 | 1,446.5000 | ||||||
Cash and Cash Equivalents | 768.3000 | 884.3000 | 1,080.6000 | 1,083.3000 | 1,459.3000 | ||||||
Current Assets | 3,276.6000 | 3,708.7000 | 4,197.7000 | 4,289 | 5,862.9000 | ||||||
Total Assets | 8,515.3000 | 9,012.4000 | 9,580.6000 | 9,634.7000 | 27,219.5000 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 143.3000 | 184.1000 | 146.3000 | 167.1000 | 284.8000 | ||||||
Long-term debt | - | - | - | 1,425.5000 | 11,556.3000 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | 3,150.2000 | ||||||
Liabilities | 3,000.5000 | 3,146.1000 | 3,280.5000 | 3,112.1000 | 17,330.1000 | ||||||
Share Capital | 2.5000 | 2.6000 | 2.6000 | 2.7000 | 3 | ||||||
Total Equity | 5,507.2000 | 5,860.9000 | 6,297.3000 | 6,522.6000 | 9,889.4000 | ||||||
Minority Interests | 7.6000 | 5.4000 | 2.8000 | 1.8000 | 1.5000 | ||||||
Total liabilities equity | 8,515.3000 | 9,012.4000 | 9,580.6000 | 9,634.7000 | 27,219.5000 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4,451.8000 | 4,471.7000 | 4,623.4000 | 4,673.3000 | 5,997.8000 | ||||||
Depreciation (total) | - | 96 | - | 375.8000 | 337.4000 | ||||||
Operating Result | 1,024.1000 | 1,047.4000 | 1,035.6000 | 1,034.7000 | 467.3000 | ||||||
Interest Income | -45.2000 | -57.3000 | -54.5000 | 11.9000 | 9.4000 | ||||||
Income Before Taxes | 978.9000 | 990.1000 | 981.1000 | 943.9000 | 153.2000 | ||||||
Income Taxes | 218.9000 | 237.2000 | 221.9000 | 224.9000 | 7 | ||||||
Minority Interests Profit | .8000 | 2.1000 | 1.8000 | -1.1000 | -.8000 | ||||||
Net Income | 760.8000 | 755 | 761 | 720.1000 | 147 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 1,176.9000 | 1,151.9000 | 963.1000 | 1,052.8000 | 816.7000 | ||||||
Cash Flow from Investing Activities | -624.4000 | -592.1000 | -282.5000 | -469.4000 | -7,557.9000 | ||||||
Cash Flow from Financing | -455.8000 | -436.5000 | -467.3000 | -562.4000 | 7,139.8000 | ||||||
Decrease / Increase in Cash | 99.4000 | 116 | 196.3000 | 2.7000 | 376 | ||||||
Employees | 8,700 | 9,300 | 9,500 | 10,000 | 17,500 |